The clinical research of theJiawei-Danggui-Buxue decoction for the patients with postoperative hemorrhage after TKA
10.3760/cma.j.issn.1673-4246.2017.02.007
- VernacularTitle:加味当归补血汤治疗人工全膝关节置换术后失血性贫血临床研究
- Author:
Chao LU
;
Jichao YIN
;
Jing REN
;
Yufeng LU
;
Weikun HOU
;
Yangquan HAO
;
Hao GUO
- Keywords:
Postoperative hemorrhage;
Anemia;
Arthroplasty,replacement,knee;
AngelicaeSinensis Danggui-Buxue decoction;
Ferrous Succinate Tablets
- From:
International Journal of Traditional Chinese Medicine
2017;39(2):121-123
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the effect ofJiawei-Danggui-Buxue decoction in the treatment for the patients with hemorrhagic anemia after total knee arthroplasty (TKA).Methods A total of 63 TKA patients with hemorrhagic anemia were included, and were divided into the treatment group (31 patients) and the control group (32 patients). All patients started to take medicine the second day after surgery. The control group took the Ferrous Succinate Tablets and the treatment group took Jiawei-Danggui-Buxue decoction in the following 4 weeks. The Hb and Hct were detected,and the changes of TCM syndrome scores and the total effect rates of anemiawere observed.Results The total effect rate of TCM syndrome scores in the treatment group was 93.54%, which was significantly higher than control group 83.87% (P<0.05); The total effect rate of anemia in the treatment group was 90.32%, which is significantly higher than control group 75.00% (P<0.05). At the fifteenth day after operation,. And at the postoperative 29th day, the levels of Hemoglobin (129.61 ± 13.02 g/Lvs. 113.35 ± 15.46 g/L,t=6.245) and Hematocrit (0.45% ± 0.03 %vs. 0.41% ± 0.04%,t=5.962) in the treatment group were significantly higher than those in the control group (P<0.05).Conclusions TheJiawei-Danggui-Buxue decoctionimprovethe Hb, HCT and the clinical effect rates of anemia and TCM syndromes for the patients with hemorrhagic anemia after TKA.
